Trulieve Cannabis

TRLV · NYSE

$10.79+$0.51 (+4.96%)TodayMarket closed ·
Prev close $10.28

Latest news

  • News

    Full Transcript: Trulieve Cannabis Q2 2026 Earnings Call

  • Press releasePRNewswire

    Trulieve Repays $65 Million Mortgage Strengthening Balance Sheet

  • Press releasePRNewswire

    Trulieve Cannabis Corp. to Hold Third Quarter 2026 Results Conference Call on November 5, 2026

  • NewsAvi Kapoor

    Crude Oil Rises Over 1%; Conagra Brands Earnings Top Views

  • NewsAvi Kapoor

    Concentrix Posts Mixed Q3 Results, Joins Cal-Maine Foods And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session

  • Press releasePRNewswire

    Trulieve Announces Exclusive Master Licensing Agreement with Connected for Florida and Texas

  • Press releasePRNewswire

    Trulieve Cannabis Corp. Added to S&P Total Market and S&P Completion Indices

  • Press releasePRNewswire

    Trulieve to Open Medical Cannabis Dispensary in Dunwoody, Georgia

  • Press releasePRNewswire

    Trulieve Announces September 2026 Event Participation

  • Press releasePRNewswire

    Happy Health Raises $75 Million for Healthcare in the Home: NYSE Content Update

  • Press releasePRNewswire

    Trulieve to Ring The Closing Bell at the New York Stock Exchange as First U.S. Cannabis Company Listed on the NYSE

  • Press releasePRNewswire

    Trulieve Completes Redomicile from British Columbia to Delaware

  • News

    Trulieve Cannabis Q2 Adj. EPS $0.11 Beats $0.06 Estimate, Sales $271.000M Beat $268.494M Estimate

  • Press releasePRNewswire

    Trulieve Reports Second Quarter 2026 Results

  • Press releasePRNewswire

    Trulieve Announces August 2026 Event Participation

  • Press releasePRNewswire

    Trulieve to Open Medical Cannabis Dispensary in Marco Island, Florida

  • Press releasePRNewswire

    Trulieve Cannabis Corp. to Hold Second Quarter 2026 Results Conference Call on August 7, 2026

  • Press releasePRNewswire

    Trulieve Named to TIME's America's Best Companies 2026 List

  • Press releasePRNewswire

    Trulieve Announces Planned Termination of Executive Automatic Securities Disposition Plan

  • NewsAvi Kapoor

    Jim Cramer Calls CAVA 'Tasty, Clean, Fun,' Says Make This Biotech 'Your Speculation'

  • NewsErica Kollmann

    Trulieve Makes History As First US Cannabis Stock On NYSE

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.